EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Effectiveness of self‐sampling human papillomavirus test on precancer detection and screening uptake in Japan : The ACCESS randomized controlled trial

Misuzu Fujita iD, Kengo Nagashima iD, Minobu Shimazu, Misae Suzuki, Ichiro Tauchi, Miwa Sakuma, Setsuko Yamamoto, Hideki Hanaoka, Makio Shozu, Nobuhide Tsuruoka, Tokuzo Kasai, Akira Hata

International Journal of Cancer · 2024

DOI: 10.1002/ijc.34970 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Misuzu Fujita und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Research, Chiba Foundation for Health Promotion and Disease Prevention, Chiba, Japan. Hauptthemen laut MEDLINE: Papillomavirus Infections, Uterine Cervical Neoplasms, Early Detection of Cancer, Uterine Cervical Dysplasia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science (JSPS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Japan is lagging in cervical cancer prevention. The effectiveness of a self‐sampling human papillomavirus (HPV) test, a possible measure to overcome this situation, has not yet been evaluated. A randomized controlled trial was performed to evaluate the effectiveness of a self‐sampling HPV test on detection of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) and screening uptake. Women between 30 and 58 years old who did not participate in the cervical cancer screening program for ≥3 years were eligible and assigned to the intervention group (cytology or self‐sampling HPV test) or control group (cytology). Participants assigned to the intervention group were sent a self‐sampling kit according to their ordering (opt‐in strategy). A total of 7337 and 7772 women were assigned to the intervention and control groups, respectively. Screening uptake in the intervention group was significantly higher than that in the control group (20.0% vs. 6.4%; risk ratio: 3.10; 95% confidence interval [CI]: 2.82, 3.42). The compliance rate with cytology triage for HPV‐positive women was 46.8% (95% CI: 35.5%, 58.4%). CIN2+ was detected in five and four participants in the intervention and control groups, respectively; there was no difference for intention‐to‐screen analysis (risk ratio: 1.32; 95% CI: 0.36, 4.93). Self‐sampling of HPV test increased screening uptake; however, no difference was observed in the detection of CIN2+, probably due to the low compliance rate for cytology triage in HPV‐positive women. Efforts to increase cytology triage are essential to maximize precancer detections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsUterine Cervical NeoplasmsEarly Detection of CancerUterine Cervical DysplasiaHumansFemaleMiddle AgedAdultJapanPapillomaviridaeVaginal SmearsSpecimen HandlingMass ScreeningPrecancerous ConditionsHuman Papillomavirus Viruses

Stichwörter der Autor:innen

HPV DNA testscancer screeningcervical cancerrandomized controlled trial

Autor:innen und Institutionen

  • Department of Health Research, Chiba Foundation for Health Promotion and Disease Prevention, Chiba, Japan.
  • Department of Public Health, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Shinjuku-ku, Japan.
  • Research Center for Medical and Health Data Science, The Institute of Statistical Mathematics, Tachikawa, Japan.
  • Clinical Research Center, Chiba University Hospital, Chiba, Japan.
  • Municipal Health Center, Ichihara, Japan.

ORCID-Profile: Misuzu Fujita, Kengo Nagashima

Förderung

  • Japan Society for the Promotion of Science (JSPS)

Zitieren

APA

Fujita, M., Nagashima, K., Shimazu, M., Suzuki, M., Tauchi, I., Sakuma, M., Yamamoto, S., Hanaoka, H., Shozu, M., Tsuruoka, N., Kasai, T., & Hata, A. (2024). Effectiveness of self‐sampling human papillomavirus test on precancer detection and screening uptake in Japan : The ACCESS randomized controlled trial. International Journal of Cancer. https://doi.org/10.1002/ijc.34970

Vancouver

Fujita M, Nagashima K, Shimazu M, Suzuki M, Tauchi I, Sakuma M, et al. Effectiveness of self‐sampling human papillomavirus test on precancer detection and screening uptake in Japan : The ACCESS randomized controlled trial. International Journal of Cancer. 2024. doi:10.1002/ijc.34970

BibTeX
@article{Fujita2024,
  author = {Fujita, Misuzu and Nagashima, Kengo and Shimazu, Minobu and Suzuki, Misae and Tauchi, Ichiro and Sakuma, Miwa and Yamamoto, Setsuko and Hanaoka, Hideki and Shozu, Makio and Tsuruoka, Nobuhide and Kasai, Tokuzo and Hata, Akira},
  title = {Effectiveness of self‐sampling human papillomavirus test on precancer detection and screening uptake in Japan : The ACCESS randomized controlled trial},
  journal = {International Journal of Cancer},
  year = {2024},
  doi = {10.1002/ijc.34970}
}
Kostenlos starten →